Gujrathi Sheila 4
4 · Janux Therapeutics, Inc. · Filed Nov 7, 2024
Insider Transaction Report
Form 4
GUJRATHI SHEILA
Director
Transactions
- Other
Common Stock
2024-11-05+4,611→ 115,139 total
Footnotes (1)
- [F1]Represents receipt of securities in a pro rata, in-kind distribution, and not a purchase of securities, by ABV SPV I GP LLC, of which Reporting Person is a member.